|
Title
|
|
|
|
Stage IIIA-N2 NSCLC : a review of its treatment approaches and future developments
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Few issues are as controversial in non-small cell lung cancer as the management of patients with stage IIIA-N2 non-small cell lung cancer. This manuscript reviews the reasons and the biases inherent to this controversy and discusses the different treatment approaches with emphasis on survival as evidenced by meta-analyses and large randomised clinical trials. Prospects on novel treatment modalities and future research opportunities are presented. (C) 2009 Elsevier Ireland Ltd. All rights reserved. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Lung cancer: journal of the International Association for the Study of Lung Cancer / International Association for the Study of Lung Cancer [Aurora, Colo.] - Amsterdam
|
|
|
Publication
|
|
|
|
Amsterdam
:
2009
|
|
|
ISSN
|
|
|
|
0169-5002
|
|
|
DOI
|
|
|
|
10.1016/J.LUNGCAN.2009.02.007
|
|
|
Volume/pages
|
|
|
|
65
:3
(2009)
, p. 257-267
|
|
|
ISI
|
|
|
|
000269431500001
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|